Humphrey Fonge

Dr. Fonge is full professor at the Faculty of Pharmacy where he recently joined from the University of Saskatchewan, where he was full professor. Dr. Fonge completed his PhD in radiopharmacy at Katholieke Universiteit Leuven (KU Leuven) in Belgium, and postdoctoral fellowship at the University of Toronto. Additionally, he completed an MBA from the Rotman School of Business at the University of Toronto. Dr. Fonge’s education and research is centered around the development of novel biologic radiopharmaceuticals (re-named as theranostics) that are used to improve the management of different cancers. Dr. Fonge brings vast experience in nuclear medicine science and will complement the existing team at the newly installed Cyclotron Facility at the CHU de Québec-Université Laval Research Center, as well as nuclear medicine physicians and oncologists, to advance new agents to patient care.